<DOC>
	<DOCNO>NCT01230073</DOCNO>
	<brief_summary>Remote monitoring implantable cardioverter defibrillator ( ICD ) promise new development ICD therapy show technically feasible safe.While data safety feasibility remote monitor favour technology , patients´ treatment satisfaction sufficiently investigate . To date , one small , non-randomised study investigate patients´ treatment satisfaction highly select highly motivated patient time implantation 12 month thereafter7 . Therefore , aim San Remo Trial investigate factor associate patients´ willingness accept new method follow-up broad basis ICD recipients determine treatment satisfaction ICD therapy randomise , prospective trial .</brief_summary>
	<brief_title>Treatment Satisfaction Implantable Cardioverter Defibrillator Recipients</brief_title>
	<detailed_description />
	<criteria>ICD indication accord current national international guideline Patient available followup study period Clinically unstable medical condition require regular outpatient clinic followup</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>ICD</keyword>
	<keyword>Home-Monitoring</keyword>
	<keyword>Quality life</keyword>
</DOC>